Following the innovation road: down the critical path initiative
SAN DIEGO – A decade has transpired since the FDA released its seminal report Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products in March 2004. The FDA did not pull any punches at that time in identifying the industry's inability to improve on the run rate of new product development despite having at its disposal advanced discovery tools such as genomics and investing billions of dollars into research and development.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter